CN
213-332-8
Applied Filters:
Keyword:'213-332-8'
Showing 1-26 of 26 results for "213-332-8" within Technical Documents
Product Information Sheet - 11442066001
ready-to-use tablets 20 tablets 11 697 471 001
NBT/BCIP Stock Solution 8 ml 11 681 451 001
NBT Solution 3 ml
(300 mg)
11 383 213 001
NBT crystals 5 g 11 585 029 001
Labeling of Biomolecules
XP725 Antibody Number-Lot Number 071M4826
.4 301 302 303 304 325 326 327 328 349 350 351 352 373 374 375 376
4.5 305 306 307 308 329 330 331 332 353 354 355 356 377 378 379 380
4.64. 309 310 311 312 333 334 335
Product Information Sheet-11383221001
Conjugate, 500 U 11 089 153 001
Tween 20 50 ml, 5 x 10 ml 11 332 465 001
4-Nitro blue tetrazolium chloride (NBT) 3 ml, 300 mg 11 383 213 001
DIG Wash and Block Buffer Set 1 set, 30 blots
Product Information Sheet-11383213001
11 112 481 001
Streptavidin-POD Conjugate, 500 U 11 089 153 001
Tween 20 50 ml, 5 x 10 ml 11 332 465 001
BCIP 3 ml, 150 mg 11 383 221 001
250 mg 10 760 994 001
1 g 11
Product Information Sheet - 11383213001
ready-to-use Tablets 20 tablets 11 697 471 001
Streptavidin-AP 150 U 11 093 266 910
Tween 20 5x 10 ml 11 332 465 001
http://www.sigmaaldrich.com/technical-service-home.html
http://www.sigmaaldrich.com
Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease
-456 (2000).
89. Gilligan, P.J., et al., Bioorg. Med. Chem., 8, 181-189 (2000).
90. Gully, D., et al., J. Pharmacol. Exp. Ther., 301, 322-332 (2002).
91. Okuyama, S., et al., J. Pharmacol. Exp. Ther., 289
XP725 Antibody List Lot 129K4830
28 AP Endonuclease A2105 328 APEX1 M NP_001632.2,NP_542379.1,NP_542380.1 y y y
692 Survivin S8191 332 BIRC5 P NP_001012270.1 y y y
17 β-Amyloid A8354 351 APP M NP_000475.1,NP_001129488.1 ,NP_001129601.1
XP725 Antibody List Lot 129K4831
28 AP Endonuclease A2105 328 APEX1 M NP_001632.2,NP_542379.1,NP_542380.1 y y y
692 Survivin S8191 332 BIRC5 P NP_001012270.1 y y y
17 β-Amyloid A8354 351 APP M NP_000475.1,NP_001129488.1 ,NP_001129601.1
XP725 Antibody List Lot 089K4791
28 AP Endonuclease A2105 328 APEX1 M NP_001632.2,NP_542379.1,NP_542380.1 y y y
692 Survivin S8191 332 BIRC5 P NP_001012270.1 y y y
17 β-Amyloid A8354 351 APP M NP_000475.1,NP_001129488.1 ,NP_001129601.1
Panorama Human Protein Functional Array-Signal Transduction
baculoviral IAP repeat-containing protein 3 330
BIRC5 baculoviral IAP repeat-containing 5 (survivin) 332
BLK B lymphoid tyrosine kinase 640
BMP7 bone morphogenetic protein 7 (osteogenic protein 1) 655
Antibody SourceBook, Sixth Edition, DIST version
€319
Anti-MMP-9 (Ab-7) Mouse mAb (GE-213) FS, IP human IM61 100 µg €338
Anti-MMP-9 (Ab-7) Mouse mAb (GE-213) FS, IP human IM61T 10 µg €77
Anti-MMP-9 (Ab-8) Mouse mAb (IA5) IB, IF; NOT FS, NOT PS
Top Trends in Single-use Biomanufacturing
Single-Use Bio-Process Equipment that Causes Poor
Cell Growth Performance Biotechnol. Prog. 2014; 30(2): 332-337.
9. Hammond M, Nunn H, Rogers G, Lee H, Marghitoiu A-L, Perez L, Nashed-Samuel Y,
Anderson
XP725 Antibody List
y
331 HDAC-5 H8163 84580, 10014, 15184 Hdac5,HDAC5 XP_001081495.1,NP_005465.2,NP_034542.3 P y y y
332 HDAC-6 H2287 15185, 10013 HDAC6,Hdac6 NP_034543.2,NP_006035.2 P y y n/d
333 HDAC-7 H2537 84582, 56233
XP725 Antibody List 013M4793
y
331 HDAC-5 H8163 84580, 10014, 15184 Hdac5,HDAC5 XP_001081495.1,NP_005465.2,NP_034542.3 P y y y
332 HDAC-6 H2287 15185, 10013 HDAC6,Hdac6 NP_034543.2,NP_006035.2 P y y n/d
333 HDAC-7 H2537 84582, 56233
XP725 Worksheet for Lot Number 071M4826
326 2 3 5 6 Centrin C7736
327 2 3 5 7 Chk1 C9358
328 2 3 5 8 Chk1 C9358
329 2 3 6 1 Chk2 C9108
330 2 3 6 2 Chk2 C9108
331 2 3 6 3 Chk2 C9233
332 2 3 6
List of Antibodies
Control NA
330 HDAC-5 H4538 M y y y
331 HDAC-5 H8163 P y y y
332 HDAC-6 H2287 P y y n/d
333 HDAC-7 H2537 P y y y
334 HDAC-7 H6663 M y y n/d
335 HDAC-8 H6412 M y n/d n/d
336 Anti Cy3+Cy5
3D BIOPRINTING: Printing a Brighter Future
Vijayavenkataraman, S.; Yan, W.-C.; Lu, W. F.; Wang, C.-H.; Fuh, J. Y. H.
Adv. Drug Deliv. Rev. 2018, 132, 296–332.
(5) Fonseca, A. C.; Melchels, F. P. W.; Ferreira, M. J. S.; Moxon, S. R.;
Potjewyd, G.; Dargaville
3D BIOPRINTING: Printing a Brighter Future
Vijayavenkataraman, S.; Yan, W.-C.; Lu, W. F.; Wang, C.-H.; Fuh, J. Y. H.
Adv. Drug Deliv. Rev. 2018, 132, 296–332.
(5) Fonseca, A. C.; Melchels, F. P. W.; Ferreira, M. J. S.; Moxon, S. R.;
Potjewyd, G.; Dargaville
Brochure: Chromolith® Monolithic Silica HPLC Columns for small and large molecule separation
buffer, pH 3.0
Gradient with
flow gradient:
Initial composition: 0 – 8 min 55% A 45% B
isocratic, flow increases from 213 μL/min to
425 μL/min, 8.1 – 20 min 65% A 35% B isocratic,
flow 850 μL/min
TLC Application compilation
85/15 7,0
5 BSA digested 2,0 water/ACN 85/15 7,0
TLC Application Note 332
Chrombook (WEB-Version)
results are always the same:
safe and sound.
www.merck-chemicals.com/preparative-hplc
332
Contents05
Preparative HPLC page 333
Scaling the separation page 348
Hibar® customized pre-packed
Halal Certificate
330. ACETOVANILLONE W508454 C44278 HC-23SILC11
331. Alginic Acid W800014 B95987 HC-23SIMI37
332. Allyl Butyrate W202118 C32914 HC-23SI6N49
333. ALLYL CYCLOHEXANEPROPIONATE 98%, FCC, FG W202606
Halal Certificate
330. ACETOVANILLONE W508454 C44278 HC-22SI3Y32
331. Alginic Acid W800014 B95987 HC-22SIZL58
332. Allyl Butyrate W202118 C32914 HC-22SIHX70
333. ALLYL CYCLOHEXANEPROPIONATE 98%, FCC, FG W202606
Perfection in every dimension - Inorganic Reagents catalog
solutions Volumetric solutions 132
Volumetric standards Standard reference materials and buffers 172
332
Glossary W-Z
Keywords Chapter Page
W Water determination Karl Fischer reagents and
Katalog neoLab
213
3
Multi-Rack, Coloured, 40 spaces
Rack for reaction vessels is usable in
both ways.
With 40 places each in 6 different col-
ours.
Front side for
32 reaction vessels 0.5 ml and
8 pieces
Perfección en todas sus dimensiones. Catálogo de reactivos inorgánicos
Título determinación Reactivos Karl Fischer 146
Título determinación Materiales de Referencia 172
332
Glosario T-V
Palabra clave Capítulo Página
T Trazabilidad Materiales de Referencia 172